JHENG, Pei-Ru, Chia-Che CHIANG, Jiunn-Horng KANG, Yu-Jui FAN, Kevin C. -W. WU, Yan-Ting CHEN, Jia-Wei LIANG, Nima BOLOUKI, Jyh-Wei LEE, Jang-Hsing HSIEH and Er-Yuan CHUANG. Cold atmospheric plasma-enabled platelet vesicle incorporated iron oxide nano-propellers for thrombolysis. Materials Today Bio. Elsevier, 2023, vol. 23, December, p. 1-14. ISSN 2590-0064. Available from: https://dx.doi.org/10.1016/j.mtbio.2023.100876.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Cold atmospheric plasma-enabled platelet vesicle incorporated iron oxide nano-propellers for thrombolysis
Authors JHENG, Pei-Ru, Chia-Che CHIANG, Jiunn-Horng KANG, Yu-Jui FAN, Kevin C. -W. WU, Yan-Ting CHEN, Jia-Wei LIANG, Nima BOLOUKI (364 Islamic Republic of Iran, belonging to the institution), Jyh-Wei LEE, Jang-Hsing HSIEH and Er-Yuan CHUANG.
Edition Materials Today Bio, Elsevier, 2023, 2590-0064.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10305 Fluids and plasma physics
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 8.200 in 2022
RIV identification code RIV/00216224:14310/23:00133048
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.mtbio.2023.100876
UT WoS 001128488200001
Keywords in English Cold atmospheric plasma; Iron oxide; Platelet vesicle; Phototherapy; Magnetotherapy; Thrombolysis
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 21/2/2024 15:28.
Abstract
A new approach to treating vascular blockages has been developed to overcome the limitations of current thrombolytic therapies. This approach involves biosafety and multimodal plasma-derived theranostic platelet vesicle incorporating iron oxide constructed nano-propellers platformed technology that possesses fluorescent and magnetic features and manifold thrombus targeting modes. The platform is capable of being guided and visualized remotely to specifically target thrombi, and it can be activated using near-infrared phototherapy along with an actuated magnet for magnetotherapy. In a murine model of thrombus lesion, this proposed multimodal approach showed an approximately 80% reduction in thrombus residues. Moreover, the new strategy not only improves thrombolysis but also boosts the rate of lysis, making it a promising candidate for time-sensitive thrombolytic therapy.
Links
90097, large research infrastructuresName: CEPLANT
PrintDisplayed: 30/6/2024 10:39